Skip to main navigation Skip to search Skip to main content

SWOG S1203: A Randomized Phase III Study of Standard Cytarabine Plus Daunorubicin (7+3) Therapy Versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)

  • Guillermo Garcia-Manero
  • , Megan Othus
  • , John M. Pagel
  • , Jerald P. Radich
  • , Min Fang
  • , David A Rizzieri
  • , Guido Marcucci
  • , Stephen A. Strickland
  • , Mark Litzow
  • , Mary Lynn Savoie
  • , Bruno C. Medeiros
  • , Mikkael A. Sekeres
  • , Tara L. Lin
  • , Geoffrey L. Uy
  • , Bayard L Powell
  • , Jonathan E. Kolitz
  • , Richard A. Larson
  • , Richard M. Stone
  • , David F. Claxton
  • , James Essell
  • Selina Luger, Sanjay R. Mohan, Anna Moseley, Frederick R. Appelbaum, Harry P. Erba

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalBlood
Volume128
StatePublished - Dec 2 2016

Disciplines

  • Medicine and Health Sciences
  • Pediatrics
  • Immunology and Infectious Disease

Cite this